Rockefeller Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Buy
42,613
+3,550
+9% +$278K 0.01% 925
2025
Q1
$2.83M Sell
39,063
-1,402
-3% -$102K 0.01% 909
2024
Q4
$3.01M Sell
40,465
-174,262
-81% -$12.9M 0.01% 872
2024
Q3
$14.2M Sell
214,727
-9,925
-4% -$656K 0.04% 435
2024
Q2
$20.8M Buy
224,652
+13,027
+6% +$1.2M 0.06% 306
2024
Q1
$20.2M Buy
211,625
+14,434
+7% +$1.38M 0.06% 323
2023
Q4
$15M Sell
197,191
-19,350
-9% -$1.48M 0.05% 357
2023
Q3
$15M Sell
216,541
-9,415
-4% -$652K 0.06% 325
2023
Q2
$21.3M Sell
225,956
-41,642
-16% -$3.93M 0.08% 246
2023
Q1
$22.1M Buy
267,598
+203,787
+319% +$16.9M 0.1% 235
2022
Q4
$4.76M Sell
63,811
-262,234
-80% -$19.6M 0.02% 539
2022
Q3
$26.9M Sell
326,045
-4,317
-1% -$357K 0.14% 160
2022
Q2
$31.4M Buy
330,362
+2,601
+0.8% +$247K 0.17% 140
2022
Q1
$38.6M Buy
327,761
+765
+0.2% +$90.1K 0.19% 126
2021
Q4
$42.4M Buy
326,996
+6,434
+2% +$833K 0.2% 122
2021
Q3
$36.3M Sell
320,562
-15,922
-5% -$1.8M 0.19% 129
2021
Q2
$34.8M Buy
336,484
+13,673
+4% +$1.42M 0.2% 122
2021
Q1
$27M Buy
322,811
+12,045
+4% +$1.01M 0.18% 132
2020
Q4
$28.4M Sell
310,766
-24,359
-7% -$2.22M 0.21% 115
2020
Q3
$26.7M Sell
335,125
-3,401
-1% -$271K 0.25% 101
2020
Q2
$23.4M Buy
338,526
+9,579
+3% +$662K 0.24% 91
2020
Q1
$20.7M Sell
328,947
-11,883
-3% -$747K 0.27% 81
2019
Q4
$26.5M Buy
340,830
+1,239
+0.4% +$96.3K 0.33% 71
2019
Q3
$24.9M Buy
339,591
+5,166
+2% +$379K 0.34% 67
2019
Q2
$20.6M Sell
334,425
-9,645
-3% -$594K 0.29% 87
2019
Q1
$21.9M Buy
344,070
+19,683
+6% +$1.26M 0.31% 77
2018
Q4
$16.6M Sell
324,387
-6,420
-2% -$328K 0.29% 83
2018
Q3
$19.2M Buy
330,807
+144
+0% +$8.36K 0.29% 88
2018
Q2
$16M Sell
330,663
-70,662
-18% -$3.43M 0.26% 89
2018
Q1
$18.7M Buy
+401,325
New +$18.7M 0.31% 83